Welcome to the inaugural CellTech2013 conference and exhibition. We have re-branded our Stem Cells World Congress / Circulating Tumor Cells / Cell Culture meeting for 2013 and expanded the scope of the event to include five conference tracks to enhance the overall experience of attendees.
Given the increasing interest in the analysis of cells in research, drug discovery and clinical applications, we are launching a 5-track conference bringing together all the key stakeholders in this space:
- Cell-based Assays
- Flow Cytometry
- Cell Culture
- Circulating Tumor Cells (CTCs)
- Cancer & Stem Cells
The Cell-based Assays and Flow Cytometry tracks will describe the research advances in, and the utility of, this class of assays for drug discovery, toxicity screening and drug development as well as methods for cell visualization. Cell Culture is focused on bioprocessing and bioproduction—given the interest in biologics and biosimilars, this is a must attend for companies seeking entry into this field. CTCs and CSCs represent the new frontier for cancer research, screening, biomarker development and patient monitoring in the future. These two tracks will highlight research and clinical advances in these fields.
Senior Vice President, The California Institute for Regenerative Medicine
Principal Investigator, La Jolla Bioengineering Institute
Professor of Anatomy and Neurobiology, University of California, Irvine
Director, University College Dublin
Director, Memorial Sloan Kettering Cancer Center
Senior Investigator, National Institutes of Health
|Corporate Sponsors||Media Sponsors||Networking|